Main | GC Biopharma

<!doctype html> <html lang="ko"> <head> <title>Main | GC Biopharma</title> <meta name="google-site-verification" content="d0aLDXXABr634-R4XaHY_QRxuCJEE-Dz2wLPLnol-Mo" /> <meta http-equiv="X-UA-Compatible" content="IE=edge">  <meta property="og:title" content="GC녹십자"> <meta property="og:url" content="http://www.globalgreencross.com"> <meta property="og:type" content="website"> <meta property="og:image" content="../images/common/logo.png"> <meta property="og:site_name" content="GC녹십자" /> <meta property="og:description" content="혈액제제와 백신제제를 비롯해 전문의약품, OTC제제 등의 의약품을 제조 및 판매하는 제약사">  <meta name="google-site-verification" content="9KXn14n6AHviZfJZJfapo7RrToKeQeIFDvk3oy3Un0M" /> <meta name="naver-site-verification" content="2c03138dd1be8ab2fd93d7c3a0a0e674be2e015d" /> <meta name="description" content="GC녹십자는 혈액제제와 백신제제를 비롯해 전문의약품, OTC제제 등의 의약품을 제조 및 판매하는 제약사이다."> <meta name="keyword" content="gcbiopharma, globalgreencross, greencross, 알부민외 제조,판매"> <link rel="canonical" href="http://www.globalgreencross.com" /> <link rel="shortcut icon" type="image/x-icon" href="/eng/images/common/favicon.ico"> <link rel="icon" href="/eng/images/common/favicon.ico"> <link rel="stylesheet" href="/eng/common/css/style.css?v=3" media="all"> <script src="/eng/common/js/jquery.js"></script> <script src="/eng/common/js/plugin/jquery-ui.min.js"></script> <script src="/eng/common/js/jquery.easing.1.3.js"></script>  <script src="/eng/common/js/cmmn.js"></script>  <link rel="stylesheet" href="/eng/common/css/esg.css" media="all">  </head> <script> Date.prototype.yyyymmdd = function() { var yyyy = this.getFullYear().toString(); var mm = (this.getMonth() + 1).toString(); var dd = this.getDate().toString(); return yyyy + (mm[1] ? mm : '0'+mm[0]) + (dd[1] ? dd : '0'+dd[0]); } function setCookie(name, value, expiredays) { var today = new Date(); today.setDate(today.getDate() + expiredays); document.cookie = name + '=' + escape(value) + '; path=/; expires=' + today.toGMTString() + ';' } function getCookie(name) { var value = document.cookie.match('(^|;) ?' + name + '=([^;]*)(;|$)'); return value? value[2] : null; } function closePopupNotToday(name, idCheck){ if($("#"+idCheck+":checked").size()){ var dt = (new Date()).yyyymmdd(); setCookie(name,dt, 1); } $("#"+name).hide(); } function closePopup(){ $("#main_popup").hide('fade'); } $(window).ready(function(){ $.ajax({ url: "mainPopup.do", type: "GET", processData: false, contentType: false }) .done(function (data, textStatus, jqXHR) { if(data.length){ for(var a in data){ var d = data[a]; var id = "popup"+d.idx; var idCheck = "idCheck"+d.idx; var dt = (new Date()).yyyymmdd(); if(getCookie(id) != dt){ var html = '<div class="common-pop" id="'+id+'" style="top: '+d.popTop+'px; left: '+d.popLeft+'px; width: '+d.popwidth+'px; height: '+d.popheight+'px;">'; html += '<div class="pop-con">'; html += '<img src="/eng/upload/'+d.sysImgName1+'" alt="'+d.imgComment1+'" />'; html += '</div>'; html += '<div class="today-close">'; html += '<p class="check-type01">'; html += '<input type="checkbox" id="'+idCheck+'" name="check"><label for="'+idCheck+'"><span></span>오늘 하루 보지 않기</label>'; html += '</p>'; html += '<a href="javascript:;" onclick="closePopupNotToday(\''+id+'\',\''+idCheck+'\');" class="btn-close">닫기</a>'; html += '</div>'; html += '</div>'; $("#popupArea").append(html); } } } }) .fail(function (jqXHR, textStatus, errorThrown) { console.log("HTTP Request Failed"); }) .always(function () { }); }); </script> <body>  <a href="#dBody" id="skipNavigation">Go to main content</a>  <div id="popupArea"> </div>  <div id="wrap" class="main">  <header id="dHead"> <div class="inner"> <h1><a href="/eng/index.do"><img src="/eng/images/common/logo.png" alt="GCPharma"/></a></h1> <nav id="gnb"> <ul> <li class="gnb-01"> <div class="one"><a href="/eng/company/company.do">About us</a></div> <div class="snb"> <dl> <dt><a href="/eng/company/company.do">About us</a></dt> <dd><a href="/eng/company/company.do">GC Biopharma</a></dd> <dd><a href="/eng/company/ceo2.do">Leadership</a></dd> <dd><a href="/eng/company/family_view1.do">Affiliates</a></dd> <dd><a href="/eng/company/ci.do">CI</a></dd> <dd><a href="/eng/company/history.do">History</a></dd> <dd><a href="/eng/company/location1.do">Locations</a></dd> </dl> </div> </li> <li class="gnb-02"> <div class="one"><a href="/eng/research/story.do">R&D</a></div> <div class="snb"> <dl> <dt><a href="/eng/research/story.do">R&D</a></dt> <dd><a href="/eng/research/story.do">R&D Story</a></dd> <dd><a href="/eng/research/research_development1.do">About R&D</a></dd> <dd><a href="/eng/research/partnership.do">Licensing</a></dd> <dd><a href="/eng/research/pipe.do">Pipeline</a></dd> <dd><a href="/eng/research/global_project.do">Global Projects</a></dd> <dd><a href="/eng/research/eap.do">Expanded Access Policy</a></dd> </dl> </div> </li> <li class="gnb-03"> <div class="one"><a href="/eng/product/list.do">Products</a></div> <div class="snb"> <dl> <dt><a href="/eng/product/list.do">Products</a></dt> <dd><a href="/eng/product/list.do">Search Products</a></dd> <dd><a href="/eng/product/cmo_about_us.do">CMO</a></dd>   </dl> </div> </li>  <li class="gnb-06"> <div class="one"><a href="/eng/esg/strategy.do">Sustainability</a></div> <div class="snb"> <dl> <dt><a href="/eng/esg/strategy.do">Sustainability<</a></dt> <dd><a href="/eng/esg/strategy.do">ESG Strategy <br>Direction</a></dd> <dd><a href="/eng/esg/management.do">Management <br>System</a></dd> <dd><a href="/eng/esg/report.do">Sustainability <br>Report</a></dd> </dl> </div> </li>  <li class="gnb-04"> <div class="one"><a href="/eng/ir/gc_stock_list1.do">Investors</a></div> <div class="snb"> <dl> <dt><a href="/eng/ir/gc_stock_list1.do">Investors</a></dt>  <dd><a href="/eng/ir/gc_stock_list1.do">IR Information</a></dd>        </dl> </div> </li> <li class="gnb-05"> <div class="one"><a href="/eng/community/social_contribution1.do">Corporate Relations</a></div> <div class="snb"> <dl> <dt><a href="/eng/community/social_contribution1.do">Corporate Relations</a></dt> <dd><a href="/eng/community/social_contribution1.do">Social Responsibility</a></dd> <dd><a href="/eng/community/video_list.do">PR</a></dd> <dd><a href="/eng/community/sns_list.do">Social Media</a></dd> <dd><a href="/eng/community/news_list.do">NEWS</a></dd> </dl> </div> </li> </ul> <a href="javascript:front.common.gnb.mouseOutHand();" class="btn-menu-close"></a> </nav> <ul class="global-menu"> <li><a href="http://www.gcbiopharma.com" target="_blank"><em>KOR</em></a></li> <li><a href="http://www.globalgreencross.com/eng/index.do" target="_blank"><em>ENG</em></a></li> <li><a href="/eng/etc/request.do">Contact us</a></li> </ul> <a href="#" class="btn-top-search"></a> </div> </header> <section id="dBody" class="main">  <div class="great-challenge" data-index="0"> <div class="main-visual"> <div class="main-visual-cell"> <div class="inner"> <div class="main-copy"> <span> <span>G</span> <span>r</span> <span>e</span> <span>a</span> <span>t</span> <span> </span> </span> <span class="copy-02"> <span>C</span> <span>h</span> <span>a</span> <span>l</span> <span>l</span> <span>e</span> <span>n</span> <span>g</span> <span>e</span> <span>.</span> </span> </div> <div class="main-sub-copy bottom"> <span>The world’s first vaccine for hemorrhagic fever with renal syndrome</span> <span>The world’s second vaccine for varicella</span> <span>The world’s third vaccine for hepatitis-B</span> <span>The world’s fourth quadrivalent vaccine for flu</span> <span class="point">Great Challenge toward the world, GC Biopharma</span> <span class="more"><a href="/eng/research/story.do">Learn More >></a></span> </div> </div> </div> <p class="visual"></p> </div> </div>   <div class="great-challenge-information" data-index="1"> <div class="d-t"> <div class="d-c"> <div class="main-information"> <div class="inner"> <h3 class="main-page-title point-color">For paths that have not yet been taken,<br>there lie two opposing attitudes:<br><em>Fear that the path ahead is unknown,<br>and savor the excitement of pioneering<br>a new path from the unknown</em></h3>  <p class="main-page-info">At GC Biopharma, our core mission revolves around one fundamental question: How can we accelerate the development of new drugs that patients have been eagerly anticipating? As trailblazers in the field of bio-pharmaceuticals, we take great pride in our ability to continuously develop groundbreaking plasma derivatives, vaccines, and recombinants. Through unwavering dedication to innovation, GC Biopharma has earned its place among the world's leading providers of life science solutions.</p>  <div class="txt-slider"> <div class="challenge-slider"> <div> <div class="slider-cell"> <h4 class="main-page-sub-title point-color">A global research center leading biotechnology R&D</h4> <p class="data-txt">The R&D Division is dedicated to the discovery of early drug candidates as well as conducting early process research and non-clinical development to confirm efficacy and toxicity. The MSAT Division focuses primarily on conducting late-process research. By splitting the R&D laboratory into these two specialized divisions, GC Biopharma aims to foster a powerful synergy within its R&D efforts to propel itself as a prominent global pharmaceutical company. The R&D Division has established a global bridgehead for new drug development by adding business development work to facilitate licensing and joint ventures.</p> </div> </div> <div> <div class="slider-cell"> <h4 class="main-page-sub-title point-color">Empowering Access: Localizing Cutting-Edge Treatments for Hepatitis-B, Hemophilia, and Other Diseases</h4> <p class="data-txt">Since its inception in 1982, GC Biopharma has become a pioneering force in the biologics market, leading the way in recombinant proteins and achieving remarkable milestones. As a result, it has succeeded in developing a novel influenza vaccine, seasonal flu vaccine, and a third-generation gene recombination therapy for hemophilia, as well as the world's second-ever treatment for Hunter syndrome using its technologies. In addition to these amazing developments, vital pharmaceuticals such as IV-Globulin (IVIG), Albumin, Hepabig, Antithrombin-III, Greeplast, and many others have grown to be essential revenue generators, bolstering its financial stability and furthering its mission to improve global healthcare outcomes.</p> </div> </div> <div> <div class="slider-cell"> <h4 class="main-page-sub-title point-color">GC Biopharma established the largest R&D facility in the Korean pharmaceutical industry.</h4> <p class="data-txt">The new GC Biopharma R&D Center was established in 2013, becoming Korea's largest pharmaceutical R&D facility. The multi-floor complex sprawls over an impressive total floor area of 28,510 𝑚<sup>2</sup> . It features facilities dedicated to new drug developments, testing manufacturing processes, producing non-clinical testing agents, and specialized analyses. These facilities include state-of-the-art research facilities and office areas, maximizing efficiency within its R&D.</p> </div> </div> </div> </div> </div> <div class="main-slider-ui"> <div class="ui-area"> <button class="btn-main-slider-prev btn-challenge-slider-prev">Prev</button> <button class="btn-main-slider-next btn-challenge-slider-next">Next</button> </div> </div> <p class="shape-obj obj-01"></p> <p class="shape-obj obj-03"></p> </div> </div> </div> </div>   <div class="great-commitment" data-index="2"> <div class="main-visual"> <div class="main-visual-cell"> <div class="inner"> <div class="main-copy"> <span> <span>G</span> <span>r</span> <span>e</span> <span>a</span> <span>t</span> <span> </span> </span> <span class="copy-02"> <span>C</span> <span>o</span> <span>m</span> <span>m</span> <span>i</span> <span>t</span> <span>m</span> <span>e</span> <span>n</span> <span>t</span> <span>.</span> </span> </div> <div class="main-sub-copy bottom"> <span>A treatment for rare Hunter syndrome (only 2,000 patients nationwide)</span> <span>A specialized flu vaccine for seniors aged 65+ </span> <span>A treatment for hemophilia, a rare disease that afflicts one in 10,000</span> <span class="point">Great Commitment for humanity, GC Biopharma</span> <span class="more"><a href="/eng/research/global_project.do">Learn More >></a></span> </div> </div> </div> <p class="visual"></p> </div> </div>   <div class="great-commitment-information" data-index="3"> <div class="d-t"> <div class="d-c"> <div class="main-information"> <div class="inner"> <h3 class="main-page-title point-color"><em>Making drugs that are difficult to make,<br>Pioneering new groundbreaking</em><br>pathways forward</h3> <p class="main-page-info">GC Biopharma has helped spearhead the development of drugs that are extremely difficult to make. We embrace the challenge as it frees patients from the despair of diseases. With our pioneering spirit, GC Biopharma continues to advance technology and develop specialized drugs that other pharmaceutical companies tend to avoid. We believe in the value of a society where everyone's quality of life is enhanced. We endeavor forward to achieve these goals globally.</p> <div class="txt-slider"> <div class="commitment-slider"> <div> <div class="slider-cell"> <h4 class="main-page-sub-title point-color">A treatment for Hunter syndrome,<br>a rare disease that affects only 2,000 patients nationwide</h4> <p class="data-txt">Hunterase, the second-ever treatment worldwide for Hunter syndrome, was developed and approved by the Korean Ministry of Food and Drug Safety in 2012. This development epitomizes GC Biopharma's advancement in bio-pharmaceutical technology. We plan to launch this innovative drug into the global market.</p> </div> </div> <div> <div class="slider-cell"> <h4 class="main-page-sub-title point-color">Treatment for Hemophilia A, a rare disease that affects 1/10,000 patients nationwide</h4> <p class="data-txt">Greengene F is a third-generation recombinant protein treatment for Hemophilia A, and the third treatment in the world has been developed. Epitomizing GC Biopharma's unrivaled technology and expertise, Phase 3 of clinical trials has reached completion in China. Greengene F was submitted to the Chinese regulatory agency and is under review. Upon launch, Greengene F will generate immense value and growth potential in the Chinese pharmaceutical market.</p> </div> </div> <div> <div class="slider-cell"> <h4 class="main-page-sub-title point-color">A specialized flu vaccine for seniors 65 and older</h4> <p class="data-txt">GC Biopharma has set out to research and develop a flu vaccine with a higher dosage for seniors. While standard flu vaccines typically elicit immune responses in 70 to 90 percent of healthy adults under 65, people aged 65 or older tend to exhibit a significantly lower immune response to these vaccines. The development of a more effective flu vaccine for this age group holds the potential to reduce the societal cost of influenza epidemics significantly.</p> </div> </div> </div> </div> </div> <div class="main-slider-ui"> <div class="ui-area"> <button class="btn-main-slider-prev btn-commitment-slider-prev">Prev</button> <button class="btn-main-slider-next btn-commitment-slider-next">Next</button> </div> </div> <p class="shape-obj obj-03"></p> </div> </div> </div> </div>   <div class="great-company" data-index="4"> <div class="main-visual"> <div class="main-visual-cell"> <div class="inner"> <div class="main-copy"> <span> <span>G</span> <span>r</span> <span>e</span> <span>a</span> <span>t</span> <span> </span> </span> <span class="copy-02"> <span>C</span> <span>o</span> <span>m</span> <span>p</span> <span>a</span> <span>n</span> <span>y</span> <span>.</span> </span> </div> <div class="main-sub-copy bottom"> <span>A producer of a varicella vaccine that is popular worldwide</span> <span>A seasonal flu vaccine that is revolutionizing the Korean and international markets</span> <span>An innovative recombinant protein drug for hemophilia</span> <span>And the world’s first verified immune cell treatment for liver cancer</span> <span class="point">Great Company globally known, GC Biopharma</span> <span class="more"><a href="/eng/company/company.do">Learn More >></a></span> </div> </div> </div> <p class="visual"></p> </div> </div>   <div class="great-company-information" data-index="5"> <div class="d-t"> <div class="d-c"> <div class="main-information"> <div class="inner"> <h3 class="main-page-title point-color">Over the last 50 years<br>To the next 50 years<br><em>For the 100 years of humanity<br>Lies the path of a centennial enterprise</em></h3> <p class="main-page-info">GC embodies its commitment and preparation for the next 50 years through a comprehensive mid- and long-term 2030 plan. This strategy represents five new global medicines, aiming to achieve 5 trillion won in sales and generate a corporate value of 50 trillion won. The goal is to establish ourselves as a leading company in the global health industry. Having already etched a new chapter in the history of the Korean pharmaceutical sector, GC now sets its sights on a transformative vision for the next half-century, driven by its profound mission and dedication to human health.</p> <h4 class="main-page-sub-title point-color">The great spirit for GC Biopharma's enterprise</h4> <p class="data-txt">For as long as we have walked in the last half century, we will continue treating diseases and improving people's health by developing medicines for patients that might be difficult but essential. GC's vision is to maximize the effectiveness and value of existing products. At the same time, we pave our path forward, strengthening the pipeline of new specialty medicines dedicated to various diseases which provide a healthier life for people globally.</p> <div class="main-cs"> <ul class="main-notice-list"> <li> <a href="/eng/community/news_view.do?idx=1382"> <span class="family-name"> Announcement </span> <span class="subject">GC Biopharma and Hanmi Pharmaceutical Receives IND Clearance for Phase 1/2 Clinical Trial from the U.S. FDA</span> <span class="date">2024.09.11</span> </a> </li> <li> <a href="/eng/community/news_view.do?idx=1383"> <span class="family-name"> Announcement </span> <span class="subject">FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A</span> <span class="date">2024.09.11</span> </a> </li> <li> <a href="/eng/community/news_view.do?idx=1384"> <span class="family-name"> Announcement </span> <span class="subject">GCBP Sponsors 2024 Spring Symposium for KASBP and Present Research Findings</span> <span class="date">2024.09.11</span> </a> </li> </ul>  </div> </div>  <p class="shape-obj obj-01"></p>  <footer class="sub-footer"> <div class="footer-community"> <div class="data"> <div class="inner"> <ul class="btn-list"> <li><a href="javascript:openPop('/eng/utility/brand_view.do' , '브랜드' , screen.width , screen.height);" class="btn-brand"><span>GC BRAND</span></a></li> <li><a href="javascript:openPop('/eng/utility/museum.do' , '뮤즈엄' , 1600 , 900);" class="btn-museum"><span>GC MUSEUM</span></a></li> <li><a href="javascript:openPop('/eng/utility/mogam_view.do' , '지씨포토' , screen.width , screen.height);" class="btn-brand"><span>GC PHOTO</span></a></li> <li><a href="javascript:front.common.family.open();" class="btn-family"><span>GC FAMILY SITE</span></a></li> </ul> <ul class="btn-sns"> <li><a href="https://www.facebook.com/GC.bio" target="_blank"><img src="/eng/images/util/btn_footer_sns_facebook.png" alt="페이스북 바로가기" /></a></li> <li><a href="https://www.instagram.com/gc.bio/" target="_blank"><img src="/eng/images/util/btn_footer_sns_instargram.png" alt="인스타그램 바로가기" /></a></li> <li><a href="https://www.youtube.com/channel/UCj80nwwDP3kTG9LQ-UrA-Vw" target="_blank"><img src="/eng/images/util/btn_footer_sns_youtube.png" alt="유투브 바로가기" /></a></li> </ul> </div> </div> <button type="button" class="btn-page-top"> <span></span> </button> </div>      <div class="footer-address"> <div class="inner"> <h2> <img src="/eng/images/common/footer_logo.png" alt="GC 녹십자" /> </h2> <address>GC Biopharma, 107 Ihyeon-ro 30-beongil, Giheung-gu, Yongin-si, Gyeonggi-do    Tel: +82-31-260-9300    Fax: +82-31-260-9413<br>Copyright ⓒ 2019 GC Biopharma corp. All rights reserved.</address> </div> </div> </footer> </div> </div> </div> </div>  </section>  <article id="emailPop" class="layer-pop-wrap"> <div class="layer-pop-parent"> <div class="layer-pop-children"> <div class="pop-data small"> <h2 class="pop-con-title">이메일집단수집거부</h2> <h3 class="pop-con-title">GC녹십자는 이메일 수집을 거부합니다</h3> <p class="pop-con-info">본 웹사이트에 게시된 이메일 주소가 전자우편 수집 프로그램이나<br>그 밖의 기술적 장치를 이용하여 무단으로 이메일 주소를 수집하는 행위를 거부하며,<br>이를 위반시 <strong class="fc01"> 정보통신망 이용촉진 및 정보보호 등에 관한 법률에 의해 형사처벌</strong>됨을<br>유념하시기 바랍니다<br><br>게시일: 2003년 9월 1일</p> <a href="#pop-close" onclick="front.pop.close(this);" class="btn-pop-close"></a> </div> </div> </div> </article>  <footer id="dFoot" class="main"> <div class="footer-community"> <div class="data"> <div class="inner"> <ul class="btn-list"> <li><a href="javascript:openPop('/eng/utility/brand_list.do' , '브랜드' , screen.width , screen.height);" class="btn-brand"><span>GC BRAND</span></a></li> <li><a href="javascript:openPop('/eng/utility/museum.do' , '뮤즈엄' , 1600 , 900);" class="btn-museum"><span>GC MUSEUM</span></a></li> <li><a href="javascript:openPop('/eng/utility/mogam_list.do' , '지씨포토' , screen.width , screen.height);" class="btn-brand"><span>GC PHOTO</span></a></li> <li><a href="javascript:front.common.family.open();" class="btn-family"><span>GC FAMILY SITE</span></a></li> </ul> <ul class="btn-sns"> <li><a href="https://www.facebook.com/GC.bio" target="_blank"><img src="/eng/images/util/btn_footer_sns_facebook.png" alt="페이스북 바로가기"/></a></li> <li><a href="https://www.instagram.com/gc.bio/" target="_blank"><img src="/eng/images/util/btn_footer_sns_instargram.png" alt="인스타그램 바로가기"/></a></li> <li><a href="https://www.youtube.com/channel/UCj80nwwDP3kTG9LQ-UrA-Vw" target="_blank"><img src="/eng/images/util/btn_footer_sns_youtube.png" alt="유투브 바로가기"/></a></li> </ul> </div> </div> <button type="button" class="btn-page-top"><span></span></button> </div> <div class="footer-menu"> <div class="inner"> <ul>  <li><a href="https://www.redwhistle.org/report/reportNew.asp?organ=7667&RType=1" target="_blank">윤리경영제보</a></li> <li><a href="/eng/etc/ethical_standard.do">지속가능경영</a></li> <li><a href="http://premion.greencross.com" target="_blank">PREMION</a></li> <li><a href="https://prm.greencross.com/" target="_blank">PRM</a></li> <li><a href="/eng/etc/policy.do"><em>개인정보처리방침</em></a></li> <li><a href="javascript:front.pop.open('emailPop');">이메일집단수집거부</a></li>  </ul> </div> </div> <div class="footer-address"> <div class="inner"> <h2><img src="/eng/images/common/footer_logo.png" alt="GC 녹십자"/></h2> <address>경기도 용인시 기흥구 이현로 30번길 107 (보정동) GC녹십자    Tel: 031-260-9300    Fax: 031-260-9413 (주) 녹십자 사업자등록번호 : 303-81-17108<br>Copyright ⓒ 2019 GC Biopharma corporate. All rights reserved.</address> </div> </div> </footer>  <section id="family"> <div class="d-t"> <div class="d-c"> <div class="inner"> <h2><img src="../../eng/images/util/familysite.png" alt=""/></h2> <ul class="family-links"> <li class="link-01"> <dl> <dt><span>Pharmaceutical</span></dt> <dd><a href="http://www.greencrossms.com/eng/main.do?lang=EN" target="_blank">GC MS</a></dd> <dd><a href="https://www.greencrosswb.com/en/" target="_blank">GC Wellbeing</a></dd> <dd><span>GC Medis</span></dd> </dl> </li> <li class="link-02"> <dl> <dt><span>Healthcare</span></dt> <dd><a href="https://gccell.com/eng/main" target="_blank">GC Cell</a></dd>  <dd><a href="https://www.gc-genome.com/" target="_blank">GC Genome</a></dd>  </dl> </li>  <li class="link-03"> <dl> <dt><span>Overseas</span></dt>  <dd><span>GC China Pharm</span></dd>  <dd><a href="http://curevovaccine.com/" target="_blank">Curevo</a></dd> <dd><span>GC Pharma do Brasil</span></dd> </dl> </li>  <li class="link-04"> <dl> <dt><span>Foundation</span></dt> <dd><a href="http://www.mogam.re.kr" target="_blank">MOGAM Institue</a></dd> <dd><a href="https://www.gclabs.co.kr/eng" target="_blank">GC Labs</a></dd> <dd><a href="http://www.gcimed.com/home/home.aspx" target="_blank">GC i-Med</a></dd> </dl> </li> <li class="link-05"> <dl> <dt><span>Others</span></dt>  <dd><span>GC Invacfarm</span></dd> </dl> </li> </ul> <button type="button" onclick="front.common.family.close();" class="btn-close"></button> </div> </div> </div> </section>  <iframe src="javascript:void(0)" name="ifr" id="ifr" width="0" height="0" style="display:none;"></iframe> <script> function openPop(_url , _name , _width , _height){ window.open(_url, _name , 'width='+_width+'px, height='+_height+'px, top=0, left=0, resizable=yes, scrollbars=yes, location=no, toolbar=no, status=no, menubar=no'); } </script>     <script language='javascript'> var _AceGID=(function(){var Inf=['gtp18.acecounter.com','8080','AM2A37766252817','AW','0','NaPm,Ncisy','ALL','0']; var _CI=(!_AceGID)?[]:_AceGID.val;var _N=0;var _T=new Image(0,0);if(_CI.join('.').indexOf(Inf[3])<0){ _T.src ="https://"+Inf[0]+'/?cookie'; _CI.push(Inf); _N=_CI.length; } return {o: _N,val:_CI}; })(); var _AceCounter=(function(){var G=_AceGID;var _sc=document.createElement('script');var _sm=document.getElementsByTagName('script')[0];if(G.o!=0){var _A=G.val[G.o-1];var _G=(_A[0]).substr(0,_A[0].indexOf('.'));var _C=(_A[7]!='0')?(_A[2]):_A[3];var _U=(_A[5]).replace(/\,/g,'_');_sc.src='https:'+'//cr.acecounter.com/Web/AceCounter_'+_C+'.js?gc='+_A[2]+'&py='+_A[4]+'&gd='+_G+'&gp='+_A[1]+'&up='+_U+'&rd='+(new Date().getTime());_sm.parentNode.insertBefore(_sc,_sm);return _sc.src;}})(); </script>  </div>  <script src="/eng/common/js/front_ui.js"></script> <script src="/eng/common/js/plugin/slick.min.js"></script> <script src="/eng/common/js/numberTicker.js"></script> <script src="/eng/common/js/TweenMax.min.js"></script> <script src="/eng/common/js/main.js"></script> <script type="text/javascript"> var mobileKeyWords = new Array('iPhone', 'iPod', 'BlackBerry', 'Android', 'Windows CE', 'LG', 'MOT', 'SAMSUNG', 'SonyEricsson','Windows Phone'); for (var word in mobileKeyWords) { if (navigator.userAgent.match(mobileKeyWords[word]) != null) { location.href = "http://m.globalgreencross.com/index.do"; break; } } </script> </body> </html>

CINXE.COM

Main | GC Biopharma